Shelekhin, CT
Alexander Shelekhin, Ridgefield, CT US
Patent application number | Description | Published |
---|---|---|
20100119930 | Alkaline cell with improved separator - An alkaline cell with improved separator. The separator is formed of two sheets. The two sheets are wound into a tube shape and the bottom edge of the wound separator is folded and heat sealed. The facing surfaces of the two sheets forming the separator body are not glued or bonded together. The two separator sheets may overlap laterally so that a portion of each sheet forms a different portion of the separator outside surface. Alternatively, the separator may be formed of two sheets wherein the first sheet forms an outer layer which completely covers the second sheet. One sheet is preferably composed of a blend of polyvinylalcohol fibers and rayon fibers and the other sheet composed of polyvinylalcohol fibers and wood pulp fibers. | 05-13-2010 |
Alexander B. Shelekhin, Ridgefield, CT US
Patent application number | Description | Published |
---|---|---|
20090202910 | Alkaline Batteries - Alkaline cells are provided that include a cathode that comprises expanded graphite. In some implementations, the cathode includes less than about 4% graphite by weight. | 08-13-2009 |
20090220855 | Battery - An alkaline battery can include a housing, a cathode within the housing, an anode, a separator between the anode and the cathode, and an alkaline electrolyte contacting the anode and the cathode. The cathode defines an anode cavity and the anode is deposited within the anode cavity. The cathode has a top surface adjacent to the anode cavity. The battery can include a protective layer deposited on the top surface of the cathode and/or a gel plug deposited over the anode. The protective layer can include a PVA layer coated over the top surface of the cathode. | 09-03-2009 |
20090305137 | Alkaline Batteries - Alkaline batteries are provided, including an anode, a cathode, and a separator disposed between the anode and cathode. The cathode porosity is selected to optimize performance characteristics of the battery. In one aspect, an alkaline cell is provided that includes (a) an anode, (b) a cathode, comprising a cathode active material, wherein the cathode has a porosity of from about 25% to about 30%, and (c) a separator disposed between the cathode and the anode. | 12-10-2009 |
Alexander Boris Shelekhin, Ridgefield, CT US
Patent application number | Description | Published |
---|---|---|
20100248012 | Alkaline Batteries - An AA alkaline cell is described. The cell includes a housing and within the housing an anode, a cathode, a separator disposed between the cathode and the anode, and an electrolyte. The anode may include about 3.3 grams of zinc particles. The cathode may include a cathode active material. The electrolyte may include an ionically conductive component in an aqueous solution. The AA alkaline cell may have a TA/Concentration ratio greater than about 4800. | 09-30-2010 |
20120310759 | COLLECTING AND REDEEMING DYNAMICALLY PRICED DEPOSITS ON GOODS - Goods may be collected and dynamically priced deposits may be redeemed to consumers. A good may be sold to a consumer and the details of the sale may be stored in a memory. A price may be collected for the good and this may be stored in the memory. A deposit on the good may be collected where the good may contain a unique code and where the deposit is correlated to a current market value of the good. The unique code may be stored with the details about the good in a memory where the unique code includes information representing at least one of whether the good is refurbish-able and whether the good contains desired recyclable material, a manufacturer of the good and a date of manufacture of the good. If the consumer consents, an indication of the consumer may be stored with the unique code. The returned good may be refurbished or recycled and the consumer may be offered a return of a deposit based on the current market value of the good which may be based on the value of the materials in the good. | 12-06-2012 |
Tatiana Shelekhin, Ridgefield, CT US
Patent application number | Description | Published |
---|---|---|
20100016295 | Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity - This invention relates to certain biphenyl amino acid compounds, compositions, and methods for treating or preventing obesity and related diseases. | 01-21-2010 |
20100234307 | PREPARATION AND USE OF BIPHENYL AMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY - This invention relates to certain biphenyl amino acid compounds, compositions, and methods for treating or preventing obesity and related diseases. | 09-16-2010 |
20110118302 | PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY - This invention relates to certain biphenyl-4-yl carbonylamino acid compounds, compositions, and methods for treating or preventing obesity and related diseases. | 05-19-2011 |
20110294776 | Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors for the Treatment of Cancer and Other Hyperproliferative Diseases - This invention relates to novel compounds of formula (I). Formula (I) in which the variable groups are as defined in the specification and claims, to pharmaceutical compositions containing them, and to a method of treatment using them for treatment of cancer. | 12-01-2011 |
Tatiana E. Shelekhin, Ridgefield, CT US
Patent application number | Description | Published |
---|---|---|
20080318935 | SUBSTITUTED IMIDAZOHETEROCYCLES - The present invention provides substituted imidazoheterocyclic compounds having the structure of formula I | 12-25-2008 |
20090149450 | SUBSTITUTED IMIDAZOHETEROCYCLES - The present invention provides substituted imidazoheterocyclic compounds having the structure of formula I | 06-11-2009 |
20110034443 | USES OF SUBSTITUTED IMIDAZOHETEROCYCLES - The present invention provides methods of prevention and treatment of cannabinoid receptor-associated diseases and conditions, wherein the method includes administering a substituted imidazoheterocyclic compounds having the structure of formula I or a pharmaceutically acceptable salt, acid salt, hydrate, solvate or stereoisomer of a compound having the structure of formula I. | 02-10-2011 |